SAM Advisors LLC Purchases 1,274 Shares of Kenvue Inc. (NYSE:KVUE)

SAM Advisors LLC increased its position in Kenvue Inc. (NYSE:KVUE) by 2.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 52,459 shares of the company’s stock after acquiring an additional 1,274 shares during the quarter. Kenvue comprises about 0.4% of SAM Advisors LLC’s investment portfolio, making the stock its 23rd biggest position. SAM Advisors LLC’s holdings in Kenvue were worth $1,213,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of KVUE. Riverview Trust Co bought a new position in shares of Kenvue during the 3rd quarter worth about $30,000. Ashton Thomas Securities LLC bought a new position in shares of Kenvue during the 3rd quarter worth about $35,000. Deseret Mutual Benefit Administrators increased its holdings in shares of Kenvue by 49.7% during the 3rd quarter. Deseret Mutual Benefit Administrators now owns 1,960 shares of the company’s stock worth $45,000 after purchasing an additional 651 shares during the period. Studio Investment Management LLC boosted its position in shares of Kenvue by 52.1% during the 2nd quarter. Studio Investment Management LLC now owns 2,468 shares of the company’s stock valued at $45,000 after acquiring an additional 845 shares in the last quarter. Finally, AlphaMark Advisors LLC acquired a new stake in shares of Kenvue during the 3rd quarter valued at about $77,000. Institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Bank of America lifted their target price on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. UBS Group boosted their target price on shares of Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. Piper Sandler boosted their target price on shares of Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Monday, September 23rd. JPMorgan Chase & Co. boosted their target price on shares of Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, Kenvue has a consensus rating of “Hold” and an average price target of $22.64.

Kenvue Stock Performance

Shares of KVUE stock opened at $23.13 on Thursday. The stock has a market cap of $44.35 billion, a P/E ratio of 42.05, a P/E/G ratio of 2.15 and a beta of 1.36. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The company has a fifty day moving average price of $22.72 and a two-hundred day moving average price of $20.62. Kenvue Inc. has a one year low of $17.67 and a one year high of $23.95.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. The firm had revenue of $3.90 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The company’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the company posted $0.31 earnings per share. As a group, equities analysts predict that Kenvue Inc. will post 1.07 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.55%. The ex-dividend date is Wednesday, November 13th. Kenvue’s dividend payout ratio is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.